March 30, 2021
Lizzie Aby
Share
To read the full article: https://www.nejm.org/doi/full/10.1056/nejmoa1509840
A new second-line therapy for Primary Biliary Cholangitis: Elafibranor
December 13, 2024
SCOPE Index
October 23, 2022
Do Steroids Improve Outcomes After Kasai Hepatoportoenterostomy
September 13, 2022
